23 Own capitalized costs
Own capitalized costs amounted to EUR 2.8 billion in the reporting year (2019: EUR 2.4 billion, 2018: EUR 2.4 billion) and mainly relate to investments in network build-out and the development of platforms for cell sites.
Own capitalized costs amounted to EUR 2.8 billion in the reporting year (2019: EUR 2.4 billion, 2018: EUR 2.4 billion) and mainly relate to investments in network build-out and the development of platforms for cell sites.